Loading organizations...
§ Private Profile · Zürich, Zurich, Switzerland
Gene therapy company developing treatments for phagocyte-related illnesses.
Somagenetix has raised $11.7M across 1 funding round.
Somagenetix has raised $11.7M in total across 1 funding round.
Somagenetix has raised $11.7M across 1 funding round. Most recently, it raised $11.7M Series A in October 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 8, 2024 | $11.7M Series A | VI Partners | — | Announced |
Somagenetix has raised $11.7M in total across 1 funding round.
Somagenetix's investors include VI Partners.